文献速递糖尿病

CREBRF糖尿病保护性rs373863828-A等位基因与毛利和太平洋裔男性早期胰岛素释放增强相关

The CREBRF diabetes-protective rs373863828-A allele is associated with enhanced early insulin release in men of Māori and Pacific ancestry.
PubMed 文献 · Diabetologia · 2021-08-21

研究纳入172名无糖尿病的超重/肥胖毛利或太平洋裔男性(56名携带A等位基因),进行混合餐耐量试验,其中44人(24名携带A等位基因)还接受了频繁采样静脉葡萄糖耐量试验和高胰岛素-正常血糖钳夹。结果发现rs373863828-A等位基因与餐后30分钟血浆胰岛素增幅更大相关,且不影响血糖或肠促胰岛素水平。静脉葡萄糖负荷后,A等位基因携带者早期(2和4分钟)血浆胰岛素和C肽浓度更高,而胰岛素敏感性指数或葡萄糖处置率无显著差异。

要点

  • rs373863828-A等位基因与餐后30分钟胰岛素增幅更大相关,不改变血糖和肠促胰岛素。
  • 静脉葡萄糖负荷后A等位基因携带者早期胰岛素和C肽更高,胰岛素敏感性无差异。
  • CREBRF p.Arg457Gln可能通过增加胰岛素释放降低2型糖尿病风险。

核心结论

  • rs373863828-A等位基因与葡萄糖刺激的胰岛素释放增加相关,而不影响胰岛素敏感性,提示CREBRF p.Arg457Gln可能通过增加胰岛素释放降低2型糖尿病风险。

研究设计与样本

  • 研究纳入172名无糖尿病的超重/肥胖毛利或太平洋裔男性,其中56名携带A等位基因,均完成混合餐耐量试验;44名(24名携带A等位基因)还接受了频繁采样静脉葡萄糖耐量试验和高胰岛素-正常血糖钳夹。
  • 采用混合线性模型分析rs373863828-A等位基因与胰岛素释放及血糖调节标志物的关联,协变量包括年龄、祖先和BMI。

主要发现

  • A等位基因与餐后30分钟血浆胰岛素增幅更大相关,而不影响血浆葡萄糖或肠促胰岛素GLP-1或GIP的升高。
  • 静脉推注葡萄糖后,A等位基因携带者在2和4分钟时血浆胰岛素和C肽浓度更高(p < 0.05),而血糖升高程度相似。
  • 尽管血浆胰岛素增加,rs373863828基因型与胰岛素敏感性指数或高胰岛素-正常血糖钳夹期间的葡萄糖处置率无显著差异(p > 0.05)。

临床怎么用

  • 对于毛利或太平洋裔超重/肥胖男性,rs373863828-A等位基因提示早期胰岛素释放增强,可能降低2型糖尿病风险,但需结合其他临床指标综合评估。

局限性

  • 研究仅纳入无糖尿病的超重/肥胖男性,结果不能推广至女性或正常体重人群。
  • 样本量有限,且仅涉及毛利和太平洋裔人群,其他种族中的适用性未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The minor A allele of rs373863828 (CREBRF p.Arg457Gln) is associated with increased BMI, but reduced risk of type 2 and gestational diabetes in Polynesian (Pacific peoples and Aotearoa New Zealand Māori) populations. This study investigates the effect of the A allele on insulin release and sensitivity in overweight/obese men without diabetes. METHODS: A mixed meal tolerance test was completed by 172 men (56 with the A allele) of Māori or Pacific ancestry, and 44 (24 with the A allele) had a frequently sampled IVGTT and hyperinsulinaemic-euglycaemic clamp. Mixed linear models with covariates age, ancestry and BMI were used to analyse the association between the A allele of rs373863828 and markers of insulin release and blood glucose regulation. RESULTS: The A allele of rs373863828 is associated with a greater increase in plasma insulin 30 min following a meal challenge without affecting the elevation in plasma glucose or incretins glucagon-like polypeptide-1 or gastric inhibitory polypeptide. Consistent with this point, following an i.v. infusion of a glucose bolus, participants with an A allele had higher early (p < 0.05 at 2 and 4 min) plasma insulin and C-peptide concentrations for a similar elevation in blood glucose as those homozygous for the major (G) allele. Despite increased plasma insulin, rs373863828 genotype was not associated with a significant difference (p > 0.05) in insulin sensitivity index or glucose disposal during hyperinsulinaemic-euglycaemic clamp. CONCLUSIONS/INTERPRETATION: rs373863828-A allele associates with increased glucose-stimulated insulin release without affecting insulin sensitivity, suggesting that CREBRF p.Arg457Gln may increase insulin release to reduce the risk of type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Burden HJ, Adams S, Kulatea B, et al. The CREBRF diabetes-protective rs373863828-A allele is associated with enhanced early insulin release in men of Māori and Pacific ancestry. Diabetologia. 2021. PMID: 34417843. doi:10.1007/s00125-021-05552-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。